Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST HCC CONTENT
Managing irAEs Across Frontline HCC Regimens Requires Clinical Judgment
Nivolumab Plus Ipilimumab Emerges as a Go-To Regimen for Frontline HCC
Interpreting Key Trial Data in the Era of IO in Advanced HCC
Analyzing Nivolumab and Ipilimumab as HCC Therapy
Proactive Management Key to Addressing TKI Adverse Events in HCC
Diagnosis and Management of Unresectable HCC Using Clinical Criteria
Exploring Differences in Survival With Lenvatinib in Recent HCC Trials
Comparable Treatment Outcomes Are Observed for Child-Pugh B in HCC
CASE-BASED ROUNDTABLES
Advertisement
Advertisement